Vancouver, British Columbia – TheNewswire - March 31, 2021 - BYND Cannasoft Enterprises Inc. (“BYND” or the “Company”) is pleased to announce that it has filed and obtained a receipt for its final long form prospectus dated March 30, 2021 (the “Prospectus”) from the British Columbia Securities Commission.  A copy of the Prospectus is available under the Company’s profile at www.sedar.com.

The Prospectus qualifies the distribution of 6,144,117 common shares of the Company to holders of special warrants issued by BYND’s predecessors, Lincoln Acquisitions Corp. and 1232986 B.C. Ltd., who amalgamated with one another to form the Company on March 29, 2021.

BYND is also pleased to announce that it has received conditional approval from the Canadian Securities Exchange (the “CSE”) for the listing of its common shares, subject to the finalization of the CSE’s listing requirements.  Once CSE final approval is received, BYND’s common shares will commence trading under the symbol "BYND". The Company will confirm the listing date for the common shares at a later date but cannot guarantee that the CSE will give final approval to the listing.

About BYND Cannasoft Enterprises Inc.

BYND, through its Israeli subsidiary (“BYND Israel”), owns and markets a proprietary customer relationship management (CRM) software product, known as “Benefit CRM”. BYND’s Benefit CRM software enables small and medium-sized businesses to optimize their day-to-day business activities such as sales management, personnel management, marketing, call centre activities and asset management. Over the last three years, BYND Israel has been developing the next generation of its Benefit CRM software, which will be cloud based. BYND Israel has also recently begun development of its New Cannabis CRM Platform, designed specifically to serve the needs of the medical cannabis industry.

BYND, through a subsidiary of BYND Israel (“Cannasoft”), has recently obtained a primary growing license for growing medical cannabis in Israel and intends to construct a farm facility to grow medical cannabis. Once the cannabis farm becomes operational, Cannasoft intends to work with strategic partners to develop and market new, proprietary cannabis infused products for sale throughout Israel and for export.

For Further Information please refer to information on SEDAR (www.sedar.com) or contact:

Gabi Kabazo

Chief Financial Officer

Tel: (604) 833-6820

e‐mail: gkabazo@gmail.com

Cautionary Note Regarding Forward-Looking Statements

This Press Release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause our actual results to differ materially from the statements made, including those factors discussed in filings made by us with the Canadian securities regulatory authorities. Should one or more of these risks and uncertainties, such as currency and interest rate fluctuations, increased competition and general economic and market factors, occur or should assumptions underlying the forward looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to put undue reliance on such forward-looking statements.

The CSE has not reviewed, approved or disapproved the content of this press release.